There are “good grounds” to believe that “mix-and-match” COVID-19 vaccine regimes can be beneficial in terms of accelerating immunization programs and making the most of available vaccine supplies, but no clear guidance can yet be given on such a strategy, according to two key EU health agencies.
It is also too early to make recommendations on the usefulness of booster vaccines, although real-world data might prove useful...